CVE:MFS

Medifocus Inc. (MFS.V) Competitors

C$0.01

0.00 (0.00 %)

(As of 09/4/2020)

Add

Compare

Today's Range

C$0.01

Now: C$0.01▼

C$0.01

50-Day Range

C$0.01

MA: C$0.01▼

C$0.01

52-Week Range

C$0.01

Now: C$0.01▼

C$0.02

Volume26,000 shs

Average Volume317,764 shs

Market CapitalizationC$1.85 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Medifocus Inc. (MFS.V) (CVE:MFS) Vs. RVV, COT, PBS, CHV, PREV, and COM

Should you be buying MFS stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Medifocus Inc. (MFS.V), including Revive Therapeutics (RVV), Cotinga Pharmaceuticals Inc. (COT.V) (COT), Pacgen Life Science Co. (PBS.V) (PBS), (CHV) (CHV), (PREV) (PREV), and 138267 (COM.TO) (COM).

Medifocus Inc. (MFS.V) vs. Revive Therapeutics Stock

Revive Therapeutics (CVE:RVV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Revive Therapeutics and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revive Therapeutics	N/A	N/A	N/A	C($0.02)	-3.64
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00

Revive Therapeutics has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Revive Therapeutics is trading at a lower price-to-earnings ratio than Medifocus Inc. (MFS.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Revive Therapeutics and Medifocus Inc. (MFS.V), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revive Therapeutics	0	0	0	0	N/A
Medifocus Inc. (MFS.V)	0	0	0	0	N/A

Profitability

This table compares Revive Therapeutics and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Revive Therapeutics	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	N/A	N/A	N/A

Summary

Medifocus Inc. (MFS.V) beats Revive Therapeutics on 3 of the 3 factors compared between the two stocks.

Medifocus Inc. (MFS.V) vs. Cotinga Pharmaceuticals Inc. (COT.V) Stock

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	C($0.12)	-0.30
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00

Cotinga Pharmaceuticals Inc. (COT.V) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Medifocus Inc. (MFS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cotinga Pharmaceuticals Inc. (COT.V)	0	0	0	0	N/A
Medifocus Inc. (MFS.V)	0	0	0	0	N/A

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	N/A	N/A	N/A

Summary

Medifocus Inc. (MFS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 2 of the 3 factors compared between the two stocks.

Medifocus Inc. (MFS.V) vs. Pacgen Life Science Co. (PBS.V) Stock

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacgen Life Science Co. (PBS.V)	C$302,079.00	6.44	C$-388,896.00	C($0.01)	-5.00
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00

Pacgen Life Science Co. (PBS.V) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Medifocus Inc. (MFS.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacgen Life Science Co. (PBS.V)	0	0	0	0	N/A
Medifocus Inc. (MFS.V)	0	0	0	0	N/A

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pacgen Life Science Co. (PBS.V)	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	N/A	N/A	N/A

Summary

Pacgen Life Science Co. (PBS.V) beats Medifocus Inc. (MFS.V) on 3 of the 5 factors compared between the two stocks.

Medifocus Inc. (MFS.V) vs. (CHV) Stock

(CHV) (CNSX:CHV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares (CHV) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(CHV)	N/A	N/A	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00

(CHV) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V).

Analyst Ratings

This is a summary of current recommendations for (CHV) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(CHV)	0	0	0	0	N/A
Medifocus Inc. (MFS.V)	0	0	0	0	N/A

Profitability

This table compares (CHV) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(CHV)	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	N/A	N/A	N/A

Summary

Medifocus Inc. (MFS.V) beats (CHV) on 1 of the 1 factors compared between the two stocks.

Medifocus Inc. (MFS.V) vs. (PREV) Stock

(PREV) (CNSX:PREV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for (PREV) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Medifocus Inc. (MFS.V)	0	0	0	0	N/A

Profitability

This table compares (PREV) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	N/A	N/A	N/A

Valuation and Earnings

This table compares (PREV) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00

(PREV) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V).

Summary

Medifocus Inc. (MFS.V) beats (PREV) on 1 of the 1 factors compared between the two stocks.

Medifocus Inc. (MFS.V) vs. 138267 (COM.TO) Stock

Medifocus Inc. (MFS.V) (CVE:MFS) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Medifocus Inc. (MFS.V) and 138267 (COM.TO), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medifocus Inc. (MFS.V)	0	0	0	0	N/A
138267 (COM.TO)	0	0	0	0	N/A

Profitability

This table compares Medifocus Inc. (MFS.V) and 138267 (COM.TO)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medifocus Inc. (MFS.V)	N/A	N/A	N/A
138267 (COM.TO)	N/A	N/A	N/A

Earnings & Valuation

This table compares Medifocus Inc. (MFS.V) and 138267 (COM.TO)'s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medifocus Inc. (MFS.V)	C$2.23 million	0.83	C$-1,849,840.00	C($0.01)	-1.00
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A

138267 (COM.TO) has lower revenue, but higher earnings than Medifocus Inc. (MFS.V).

Summary

Medifocus Inc. (MFS.V) beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.